Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age
Single Dose Open-label PK/PD, Safety and Tolerability Study of Dabigatran Etexilate Mesilate Given at the End of Standard Anticoagulant Therapy in Children Aged 1 Year to Less Than 2 Years in Conjunction With Study 1160.89
Status: Enrolling
Updated:  10/23/2015
Boehringer Ingelheim Investigational Site
mi
from
St. Louis, MO
Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age
Single Dose Open-label PK/PD, Safety and Tolerability Study of Dabigatran Etexilate Mesilate Given at the End of Standard Anticoagulant Therapy in Children Aged 1 Year to Less Than 2 Years in Conjunction With Study 1160.89
Status: Enrolling
Updated: 10/23/2015
Boehringer Ingelheim Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age
Single Dose Open-label PK/PD, Safety and Tolerability Study of Dabigatran Etexilate Mesilate Given at the End of Standard Anticoagulant Therapy in Children Aged 1 Year to Less Than 2 Years in Conjunction With Study 1160.89
Status: Enrolling
Updated:  10/23/2015
1220.19.0015 Boehringer Ingelheim Investigational Site
mi
from
Newark, NJ
Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age
Single Dose Open-label PK/PD, Safety and Tolerability Study of Dabigatran Etexilate Mesilate Given at the End of Standard Anticoagulant Therapy in Children Aged 1 Year to Less Than 2 Years in Conjunction With Study 1160.89
Status: Enrolling
Updated: 10/23/2015
1220.19.0015 Boehringer Ingelheim Investigational Site
mi
from
Newark, NJ
Click here to add this to my saved trials
Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age
Single Dose Open-label PK/PD, Safety and Tolerability Study of Dabigatran Etexilate Mesilate Given at the End of Standard Anticoagulant Therapy in Children Aged 1 Year to Less Than 2 Years in Conjunction With Study 1160.89
Status: Enrolling
Updated:  10/23/2015
Boehringer Ingelheim Investigational Site
mi
from
Pittsburgh, PA
Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age
Single Dose Open-label PK/PD, Safety and Tolerability Study of Dabigatran Etexilate Mesilate Given at the End of Standard Anticoagulant Therapy in Children Aged 1 Year to Less Than 2 Years in Conjunction With Study 1160.89
Status: Enrolling
Updated: 10/23/2015
Boehringer Ingelheim Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age
Single Dose Open-label PK/PD, Safety and Tolerability Study of Dabigatran Etexilate Mesilate Given at the End of Standard Anticoagulant Therapy in Children Aged 1 Year to Less Than 2 Years in Conjunction With Study 1160.89
Status: Enrolling
Updated:  10/23/2015
Boehringer Ingelheim Investigational Site
mi
from
Houston, TX
Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age
Single Dose Open-label PK/PD, Safety and Tolerability Study of Dabigatran Etexilate Mesilate Given at the End of Standard Anticoagulant Therapy in Children Aged 1 Year to Less Than 2 Years in Conjunction With Study 1160.89
Status: Enrolling
Updated: 10/23/2015
Boehringer Ingelheim Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age
Single Dose Open-label PK/PD, Safety and Tolerability Study of Dabigatran Etexilate Mesilate Given at the End of Standard Anticoagulant Therapy in Children Aged 1 Year to Less Than 2 Years in Conjunction With Study 1160.89
Status: Enrolling
Updated:  10/23/2015
1199.14.1259 Boehringer Ingelheim Investigational Site
mi
from
Spokane, WA
Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age
Single Dose Open-label PK/PD, Safety and Tolerability Study of Dabigatran Etexilate Mesilate Given at the End of Standard Anticoagulant Therapy in Children Aged 1 Year to Less Than 2 Years in Conjunction With Study 1160.89
Status: Enrolling
Updated: 10/23/2015
1199.14.1259 Boehringer Ingelheim Investigational Site
mi
from
Spokane, WA
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Phoenix, AZ
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Stanford, CA
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Tampa, FL
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Atlanta, GA
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Chicago, IL
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
St. Paul, MN
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
St. Paul, MN
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Kansas City, MO
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Albany, NY
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Durham, NC
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Memphis, TN
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Dallas, TX
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Houston, TX
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37)
VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Effectiveness of Group Walking Sessions for Increasing Activity in People With Peripheral Arterial Disease (The Group Oriented Arterial Leg Study [GOALS])
Increasing Activity in Peripheral Arterial Disease
Status: Enrolling
Updated:  10/27/2015
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Effectiveness of Group Walking Sessions for Increasing Activity in People With Peripheral Arterial Disease (The Group Oriented Arterial Leg Study [GOALS])
Increasing Activity in Peripheral Arterial Disease
Status: Enrolling
Updated: 10/27/2015
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Status: Enrolling
Updated:  10/28/2015
University of California-Davis
mi
from
Sacramento, CA
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Status: Enrolling
Updated: 10/28/2015
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Status: Enrolling
Updated:  10/28/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Status: Enrolling
Updated: 10/28/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Status: Enrolling
Updated:  10/28/2015
Rochester General Hospital
mi
from
Rochester, NY
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Status: Enrolling
Updated: 10/28/2015
Rochester General Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Status: Enrolling
Updated:  10/28/2015
Univ of Rochester Medical Center
mi
from
Rochester, NY
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Status: Enrolling
Updated: 10/28/2015
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Status: Enrolling
Updated:  10/28/2015
Duke University School of Medicine
mi
from
Durham, NC
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Status: Enrolling
Updated: 10/28/2015
Duke University School of Medicine
mi
from
Durham, NC
Click here to add this to my saved trials
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Status: Enrolling
Updated:  10/28/2015
Cleveland Clinic
mi
from
Cleveland, OH
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Status: Enrolling
Updated: 10/28/2015
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Status: Enrolling
Updated:  10/28/2015
Ottawa Hospital Research Institute (OHRI)
mi
from
Ottawa,
A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
A Prospective Randomized Multicenter Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients
Status: Enrolling
Updated: 10/28/2015
Ottawa Hospital Research Institute (OHRI)
mi
from
Ottawa,
Click here to add this to my saved trials
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated:  10/28/2015
Retina Group of Florida
mi
from
Fort Lauderdale, FL
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated: 10/28/2015
Retina Group of Florida
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated:  10/28/2015
Johns Hopkins Unversity
mi
from
Baltimore, MD
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated: 10/28/2015
Johns Hopkins Unversity
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated:  10/28/2015
Valley Retina Institute, P.A.
mi
from
McAllen, TX
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated: 10/28/2015
Valley Retina Institute, P.A.
mi
from
McAllen, TX
Click here to add this to my saved trials
BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT)
Beta-blocker Uptitration in Heart Failure Patients Receiving Cardiac Resynchronization Therapy With Optivol Fluid Status Monitoring System
Status: Enrolling
Updated:  10/28/2015
St. Luke's Roosevelt Hospital
mi
from
New York, NY
BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT)
Beta-blocker Uptitration in Heart Failure Patients Receiving Cardiac Resynchronization Therapy With Optivol Fluid Status Monitoring System
Status: Enrolling
Updated: 10/28/2015
St. Luke's Roosevelt Hospital
mi
from
New York, NY
Click here to add this to my saved trials
BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT)
Beta-blocker Uptitration in Heart Failure Patients Receiving Cardiac Resynchronization Therapy With Optivol Fluid Status Monitoring System
Status: Enrolling
Updated:  10/28/2015
University of Rochester
mi
from
Rochester, NY
BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT)
Beta-blocker Uptitration in Heart Failure Patients Receiving Cardiac Resynchronization Therapy With Optivol Fluid Status Monitoring System
Status: Enrolling
Updated: 10/28/2015
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT)
Beta-blocker Uptitration in Heart Failure Patients Receiving Cardiac Resynchronization Therapy With Optivol Fluid Status Monitoring System
Status: Enrolling
Updated:  10/28/2015
Jefferson Medical College
mi
from
Philadelphia, PA
BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT)
Beta-blocker Uptitration in Heart Failure Patients Receiving Cardiac Resynchronization Therapy With Optivol Fluid Status Monitoring System
Status: Enrolling
Updated: 10/28/2015
Jefferson Medical College
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening
Influence of Progesterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes
Status: Enrolling
Updated:  10/29/2015
Indiana Clinical Research Center
mi
from
Indianapolis, IN
Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening
Influence of Progesterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes
Status: Enrolling
Updated: 10/29/2015
Indiana Clinical Research Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening
Influence of Progesterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes
Status: Enrolling
Updated:  10/29/2015
Purdue University
mi
from
Indianapolis, IN
Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening
Influence of Progesterone Administration on Drug-Induced QT Interval Prolongation and Torsades de Pointes
Status: Enrolling
Updated: 10/29/2015
Purdue University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)
Targeting Systemic Inflammation to Concurrently Treat Late-Life Depression and Reduce Coronary Artery Disease Risk
Status: Enrolling
Updated:  10/30/2015
Indiana University-Purdue University Indianapolis (IUPUI)
mi
from
Indianapolis, IN
Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)
Targeting Systemic Inflammation to Concurrently Treat Late-Life Depression and Reduce Coronary Artery Disease Risk
Status: Enrolling
Updated: 10/30/2015
Indiana University-Purdue University Indianapolis (IUPUI)
mi
from
Indianapolis, IN
Click here to add this to my saved trials
How the Elderly Live With Pain in Heart Failure
How the Elderly Live With Pain in Heart Failure
Status: Enrolling
Updated:  11/2/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
How the Elderly Live With Pain in Heart Failure
How the Elderly Live With Pain in Heart Failure
Status: Enrolling
Updated: 11/2/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
Center For Clinical Research Inc.
mi
from
San Francisco, CA
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
Center For Clinical Research Inc.
mi
from
San Francisco, CA
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
University of Miami School Hospital
mi
from
Miami, FL
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
University of Miami School Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
Tufts Medical Center
mi
from
Boston, MA
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
St. Luke's Roosevelt Hospital Center
mi
from
New York City, NY
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
St. Luke's Roosevelt Hospital Center
mi
from
New York City, NY
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
Boston Med Ctr
mi
from
Boston, MA
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Inhaled NO as an Anti-inflammatory and Anti-reperfusion Agent in Infants and Children Undergoing Cardiopulmonary Bypass
A Trial of Inhaled Nitric Oxide (NO) as an Anti-Inflammatory and Anti-Reperfusion Agent in the Treatment of Infants and Children Undergoing Cardiopulmonary Bypass for Repair of Congenital Heart Disease
Status: Enrolling
Updated:  11/3/2015
St. Louis Children's Hospital
mi
from
St. Louis, MO
Inhaled NO as an Anti-inflammatory and Anti-reperfusion Agent in Infants and Children Undergoing Cardiopulmonary Bypass
A Trial of Inhaled Nitric Oxide (NO) as an Anti-Inflammatory and Anti-Reperfusion Agent in the Treatment of Infants and Children Undergoing Cardiopulmonary Bypass for Repair of Congenital Heart Disease
Status: Enrolling
Updated: 11/3/2015
St. Louis Children's Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Evaluation of Myocardial Ischemia Using Standard Single Photon Emission Computed Tomography (SPECT) With Regadenoson and Simultaneous Cardiac Echocardiography
Lexi-Echo - a Rapid, Portable, Non-radiating Diagnostic Test for Myocardial Ischemia That is Accurate Relative to Simultaneously Obtained Nuclear SPECT MPI
Status: Enrolling
Updated:  11/3/2015
University of Arizona Medical Center
mi
from
Tucson, AZ
Evaluation of Myocardial Ischemia Using Standard Single Photon Emission Computed Tomography (SPECT) With Regadenoson and Simultaneous Cardiac Echocardiography
Lexi-Echo - a Rapid, Portable, Non-radiating Diagnostic Test for Myocardial Ischemia That is Accurate Relative to Simultaneously Obtained Nuclear SPECT MPI
Status: Enrolling
Updated: 11/3/2015
University of Arizona Medical Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema
A 10 Month, Single Masked, Randomized Controlled Study to Assess Anti-VEGF Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema
Status: Enrolling
Updated:  11/3/2015
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema
A 10 Month, Single Masked, Randomized Controlled Study to Assess Anti-VEGF Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema
Status: Enrolling
Updated: 11/3/2015
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH.
Echo Study - Characterization of LV Strain Patterns in Patients With Mildly Elevated PCWP and Pulmonary Hypertension
Status: Enrolling
Updated:  11/3/2015
University of Arizona Medical Center
mi
from
Tucson, AZ
Characterization of LV Strain Patterns in Mildly Elevated PCWP and PAH.
Echo Study - Characterization of LV Strain Patterns in Patients With Mildly Elevated PCWP and Pulmonary Hypertension
Status: Enrolling
Updated: 11/3/2015
University of Arizona Medical Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Hydrogel Balloon Assisted Intracranial Aneurysm Coiling Registry
Hydrogel Balloon Assisted Intracranial Aneurysm Coiling Registry
Status: Enrolling
Updated:  11/5/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Hydrogel Balloon Assisted Intracranial Aneurysm Coiling Registry
Hydrogel Balloon Assisted Intracranial Aneurysm Coiling Registry
Status: Enrolling
Updated: 11/5/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis
A 12-Week, Randomized, Semi Double-Blinded Study Evaluating the Effects of Daily Oral High-Dose Atorvastatin or BMS-582949 on Atherosclerotic Plaque Inflammation as Determined by FDG-PET in High Risk Atherosclerotic Patients
Status: Enrolling
Updated:  11/6/2015
Southeast Clinical Research, Llc
mi
from
Chiefland, FL
Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis
A 12-Week, Randomized, Semi Double-Blinded Study Evaluating the Effects of Daily Oral High-Dose Atorvastatin or BMS-582949 on Atherosclerotic Plaque Inflammation as Determined by FDG-PET in High Risk Atherosclerotic Patients
Status: Enrolling
Updated: 11/6/2015
Southeast Clinical Research, Llc
mi
from
Chiefland, FL
Click here to add this to my saved trials